Galactomyces Ferment Filtrate in Korean K-Beauty: What Indie Founders Need to Know Before Sourcing a 90%+ Ferment Essence from a Korean ODM (2026)

If you have ever looked at the back of a viral Korean essence and seen "galactomyces ferment filtrate" listed at 75, 90, or 95 percent of the formula, you have already met the most misunderstood active in modern K-beauty. It is the ingredient SK-II built a thousand-dollar empire on under the name Pitera. It is the ingredient COSRX, Manyo, Some By Mi, and a dozen indie Korean brands have rebuilt at one-fifth the price. And it is the ingredient that, in 2026, almost every Korean ODM will offer to drop into your first brief without explaining how much the actual fermentation choice matters to what lands in the bottle.

This is the founder's guide to what galactomyces ferment filtrate actually is, what the published clinical work supports, and how to source it through a Korean ODM at indie MOQ without paying for marketing claims your bottle cannot legally make in the US.

Key Takeaways

A galactomyces ferment filtrate is the cell-free liquid left after a yeast called Galactomyces candidum (also classified as Geotrichum candidum) finishes fermenting a nutrient broth. It is mostly water plus the metabolites the yeast secreted: amino acids, peptides, B-group vitamins, organic acids, and small amounts of minerals and enzymes. The cosmetic ingredient INCI is "Galactomyces Ferment Filtrate" and use levels in finished products run from roughly 10 percent (supporting cast) to 100 percent (where the filtrate replaces the water phase entirely).

The published mechanism that matters most to a serum founder is barrier-protein activation. A 2015 study in Clinical and Experimental Dermatology showed that GFF binds and activates the aryl hydrocarbon receptor (AhR) in normal human keratinocytes, with dose-dependent upregulation of filaggrin, loricrin, occludin, claudin-1, claudin-4, and kallikrein 5 and 7 gene expression. Translation: the cells that build your stratum corneum start making more of the proteins that hold it together.

Concentrations are not interchangeable. A 5-percent ferment positioned inside a niacinamide-and-glycerin serum is a different product class than a 90-percent essence where the ferment is the formula. Choosing wrong on this question alone is the most common reason indie founders ship a "galactomyces serum" that tests well in marketing copy and feels like nothing on the face.

The 2025 fermentation literature continues to lean cautiously positive on hydration and barrier endpoints. A 2024 study in the Journal of Dermatological Science reported that GFF enhances skin barrier function and augments epidermal cell-cell interactions, and a 2023 longitudinal study in the Journal of Clinical Medicine documented cumulative hydration gains and TEWL reduction over 12 months of daily use of GFF-containing products in a real-world cohort.

For a US indie launching one to three SKUs, expect a 90 to 95 percent galactomyces ferment essence at 1,000 to 3,000 unit MOQ to cost roughly two to four dollars per 30-ml bottle ex-works at a mid-tier Korean ODM before packaging, with strain provenance, fermentation duration, and filtration grade explaining most of the spread. A 2-dollar quote and a 4-dollar quote are usually not the same product class.

The ingredient is well-tolerated in the published work, but it is not a treatment claim. Under MoCRA in the United States and the Korean MFDS framework at home, "improves barrier function" and "supports skin barrier" are cosmetic structure-function claims you can usually defend with the published mechanistic literature; "treats atopic dermatitis" or "cures eczema" are drug claims you cannot make on a cosmetic label regardless of what the keratinocyte studies show. Treat the difference seriously when you write your brand copy.

What Galactomyces Ferment Filtrate Actually Is

A ferment filtrate is not an extract. An extract pulls compounds out of a plant or food source using solvent. A ferment filtrate is what is left behind after a living microorganism has consumed a nutrient broth and excreted its own metabolites into the liquid. The microorganism is then removed by filtration or centrifugation, and the clear liquid that remains is the filtrate.

For galactomyces, the microorganism is Galactomyces candidum (also identified in older literature as Geotrichum candidum), a yeast historically associated with the surface rinds of bloomy-rind cheeses such as Camembert and certain washed-rind styles. In a cosmetic ingredient supplier's bioreactor, the strain is grown in a defined liquid medium for typically 48 to 96 hours at controlled temperature, oxygen, and pH. As the yeast metabolizes the broth, it produces a mix that includes free amino acids (notably glutamic acid, alanine, glycine, and several others identified in 2024 cosmetic chemistry literature on natural moisturizing factor profiles), small peptides, B-group vitamins with niacinamide present in detectable amounts in many commercial lots, organic acids that contribute mild buffering and very gentle exfoliation, and trace mineral content from the medium itself.

When the fermentation is complete, the broth is filtered through progressively finer membranes until the cell mass is removed. What ships to an ODM is a clear-to-pale-yellow liquid that is 80-plus percent water by mass, with the rest being the soluble metabolite fraction. The exact composition varies meaningfully between suppliers because the strain, the nutrient medium, the duration, and the filtration grade are all formulator choices, and there is no single industry-standard galactomyces ferment filtrate the way there is, for example, a single industry-standard form of hyaluronic acid molecular weight specification.

This variability is one of the points indie founders most often miss when reading two ODM quotes side by side. A "90 percent galactomyces ferment filtrate essence" from Supplier A and a"90 percent galactomyces ferment filtrate essence" from Supplier B can carry different amino acid spectra, different residual peptide content, and meaningfully different skin-feel profiles, even though the INCI label reads identically.

The Clinical Evidence, Translated for Founders

Galactomyces is one of the better-studied modern K-beauty actives, which makes it unusually pleasant to write a defensible product page about. The literature splits cleanly into three blocks: mechanism-of-action in keratinocytes, barrier function and TEWL endpoints in human skin, and inflammation and anti-inflammaging signaling.

The mechanism work centers on the aryl hydrocarbon receptor. A 2015 study by Takei and colleagues in Clinical and Experimental Dermatology (volume 40, issue 7, October 2015) screened cosmetic compounds for AhR activation and identified GFF as a positive hit. In normal human keratinocytes, GFF induced nuclear translocation of AhR and dose-dependent upregulation of CYP1A1 (the canonical AhR-target marker), along with filaggrin (FLG) and loricrin (LOR), the two best-known structural proteins of the cornified envelope. The same paper showed GFF restored FLG and LOR gene expression in keratinocytes that had been suppressed by T helper 2 cytokines, and upregulated genes encoding the tight-junction proteins occludin, claudin-1, and claudin-4, plus kallikrein 5 and 7 (the proteases that govern corneocyte desquamation). The same restoration was visible in a 3D epidermal equivalent model.

For an indie founder writing brand copy, this is the supportive evidence behind any structure-function language about barrier protein support. The mechanism is published in a peer-reviewed dermatology journal with controls and reproducible methodology. It is not a treatment claim, but it is a defensible "supports the skin barrier" claim if you cite it accurately.

The hydration and TEWL endpoints come from a longer series of papers, most recently summarized in a 2023 longitudinal study in the Journal of Clinical Medicine (volume 12, issue 3, 2023) that tracked daily application of GFF-containing skincare over 12 months in a real-world cohort and documented cumulative gains in skin hydration with correlated reduction in transepidermal water loss. A 2024 Journal of Dermatological Science paper went further into the cell-cell junction biology, showing that GFF enhances skin barrier function and augments epidermal cell-cell interactions in vitro and in reconstructed epidermis.

The third block is the anti-inflammaging signaling work. A 2022 study in the Journal of Clinical Medicine (volume 11, issue 21, article 6338) showed that GFF potentiates an anti-inflammaging system in keratinocytes through NRF2-pathway activation and downregulation of senescence-associated secretory phenotype markers. A 2022 transcriptomic analysis in the same journal (volume 11, issue 16, article 4645) found that GFF treatment in human keratinocytes shifted gene expression toward barrier, hydration, and antioxidant pathways and away from inflammatory signaling.

For a founder, this is the supportive literature for words like "soothing," "barrier-supporting," and "antioxidant," all of which are within ordinary US cosmetic structure-function claim territory if your finished product has been formulated and tested at concentrations consistent with the published work.

Why Concentration Is Not a Marketing Number

The single most common indie mistake on a galactomyces brief is treating the percentage as a marketing decision rather than a product-class decision. A 5 percent galactomyces ferment filtrate inside a niacinamide-and-panthenol serum is a different product class than a 95 percent galactomyces ferment essence. They sit at different points in the routine, they are priced differently, they smell and feel different, and they cannot legitimately be marketed against each other as "more concentrated equals more effective" because the mechanistic dose-response work in the published literature is non-linear.

The dose-response from the 2015 AhR paper showed gene-expression upregulation of FLG and LOR across the tested range, but the curve plateaus. Doubling concentration in vitro does not double the in-vivo result on a face. What concentration does change is the formulation logic around it: at 5 percent ferment, you have 95 percent of the formula left for water, humectants, emollients, viscosity modifiers, preservation system, and other actives. At 90 to 95 percent ferment, the filtrate is the water phase, and your remaining 5 to 10 percent has to do every other job: glycerin, betaine, panthenol, allantoin, preservation, sometimes a small humectant load, and that is it.

The 90-plus percent essence category, popularized by SK-II at the top of the market and by COSRX and Manyo in the mass and prestige-mass tiers, is a watery, fast-absorbing first-essence product. It sits between the toner step and the serum step in a Korean-style routine and is intended to be patted on with the hands after cleansing. It is not a moisturizer, and indie founders who position it as one tend to receive lukewarm reviews from K-beauty-literate consumers.

The 50 to 75 percent ferment category sits in the "ampoule" or "toner-essence hybrid" zone. The ferment is still the dominant character of the formula but there is room for adjuvant actives such as niacinamide at 2 to 5 percent, panthenol at 1 to 5 percent, or small amounts of peptides for marketing positioning. This is the most commonly briefed range for indie K-beauty launches because it balances the ferment authority with the room to build a differentiated formula on top.

The 5 to 20 percent ferment category turns galactomyces into a supporting cast member of a more conventional serum. The formula reads as a niacinamide serum, or a centella serum, or a peptide serum that "also contains galactomyces ferment filtrate." This is a legitimate and often more affordable starting point for a first SKU.

When you brief an ODM, name the concentration target and the product-class intent in the same sentence. "I want a 90 to 95 percent galactomyces ferment first essence in the Pitera-style category, watery skin feel, no fragrance, no color" is a brief an ODM lab will turn around quickly with a benchmark sample. "I want a galactomyces serum" without a percentage is a brief that wastes two rounds of samples while you and the lab figure out which product class you actually meant.

Inside the Korean ODM Fermentation Tank

Korean ODMs do not all make their own galactomyces ferment filtrate. Most license the filtrate from a domestic biotech ingredient supplier that runs the fermentation in dedicated bioreactors and ships drums of finished filtrate to the formulation lab. (For the broader Korean fermentation toolkit indie founders should know, our Korean bio-fermented ingredients guide covers the wider category.) Among the larger Korean biotech ingredient houses with named galactomyces ferment products are operations such as ENBS (which holds a fermentation technology patent on certain proprietary strains), and several others that supply the major Korean indie brand programs. The ODM you choose may quote the same INCI on its label, but the strain provenance, the fermentation duration, and the filtration grade will trace back to whichever upstream supplier they buy from.

This matters for three reasons. First, sensory: the amino acid and peptide profile drives the way the finished essence feels on the skin, and that profile drifts between suppliers. Second, claims: if your brand wants to lean into the published mechanism work, you want a strain and a filtrate spec that is reasonably close to what was tested in the literature, not a generic commodity filtrate from a low-tier supplier whose strain has never been characterized in print. Third, lot-to-lot consistency: a Korean ODM that buys from a single tier-one ingredient supplier with documented batch-to-batch QC will deliver a more consistent finished product than an ODM that switches between two or three lower-tier suppliers depending on which one quoted cheapest that month.

When ALTA MEET walks an indie founder through a first galactomyces brief, the three questions we put to the ODM lab before approving samples are: who is the upstream ingredient supplier, what is the strain identifier and fermentation duration on the certificate of analysis, and what is the residual amino acid and peptide profile by typical lot. Our Korean ODM pre-PO due diligence checklist covers the broader supplier-vetting workflow this slot in into. An ODM that cannot answer the first question quickly is an ODM that is buying on spot price, and the resulting essence will perform like it.

The Cost and MOQ Reality at Indie Scale

A 30-ml dropper-bottle galactomyces ferment essence at 1,000 to 3,000 unit MOQ at a mid-tier Korean ODM lands ex-works in 2026 at roughly two to four dollars per unit before packaging, depending on the supplier tier, the ferment concentration, and any adjuvant actives stacked on top. For broader context on how a Korean ODM unit-cost stack reads at indie MOQ, our Korean skincare manufacturing cost guide walks through the underlying math. The range covers a broad band of product quality, and the difference between the 2-dollar quote and the 4-dollar quote is rarely "exactly the same product, one factory is cheaper." It is usually a different ferment supplier upstream, a different strain, a different filtration grade, or a different preservation system.

To break that down at a 90 percent ferment essence at 1,000-unit MOQ in 2026, a typical indie-tier Korean ODM might quote in the band of $1.80 to $3.20 ex-works on a 30-ml fill, with the lower end matching a commodity-grade ferment from a second-tier ingredient house and the higher end matching a tier-one supplier with patented strain and characterized lot composition. Packaging on a 30-ml dropper bottle with primary fitment and unit carton runs $1.20 to $2.50 per unit at the same MOQ tier, often pushing the all-in landed cost above the formula cost itself.

Lead time for a stock-packaging, formula-from-benchmark indie launch is currently 8 to 14 weeks from approved brief to first carton on the water, and 10 to 16 weeks for a custom formulation that includes any adjuvant active layering on top of the ferment. The low-MOQ Korean skincare manufacturing guide walks through how that 1,000-unit tier opens up in 2026. The pre-2024 industry baseline of 12 to 16 weeks has compressed for stock-formula private label and has held flat for genuinely custom briefs.

For an indie launching a single galactomyces ferment essence SKU at 1,000 units in 2026, the all-in cost from approved brief to first shippable carton typically falls in the range of $5,000 to $12,000, with formula and ferment supply running roughly half the bill and packaging, label printing, US compliance (MoCRA facility registration, product listing, label review), and shipping making up the balance.

The galactomyces ferment category is one of the rare K-beauty ingredients where indie-MOQ economics genuinely work in your favor. The ferment itself is not patent-encumbered in any restrictive way for most strains and most concentrations, the manufacturing footprint is mature, and Korean ODMs compete actively on this product class because so many existing indie K-beauty brands are buying the same essence in 1,000 to 5,000 unit cycles.

I'm Liz, and I run ALTA MEET from Manhattan, NYC. Galactomyces is one of the categories where I get the most "I think my ODM quoted me the wrong product class" emails from first-time founders. If you want a quick gut-check on whether the brief you are about to send to a Korean lab actually matches the product you have in your head, grab 15 minutes free with me and we can pressure-test the percentage, the strain provenance, and the cost stack before you commit to your first sample round.

The Five Briefing Decisions Indie Founders Get Wrong

The first is the percentage decision discussed earlier. Naming the target concentration and the product-class intent together saves two rounds of samples.

The second is the strain provenance question. Most indie founders never ask the ODM which upstream supplier their galactomyces ferment filtrate comes from. The ODM will not volunteer the information unless prompted. Ask in your second email, and ask the ODM to share the certificate of analysis from the upstream supplier as part of the sample package.

The third is the preservation system. A 90-plus percent ferment essence has very little room left for a heavy preservation system, and ferment filtrates are nutritional broths from the perspective of microbial contamination. Korean ODMs handle this with combinations of phenoxyethanol, ethylhexylglycerin, 1,2-hexanediol, and similar broad-spectrum preservatives within KFDA and EU annex limits. Ask the lab for the preservation system spec on the certificate of analysis, and ask whether the formula has passed ISO 11930 preservative efficacy testing on the final ferment-loaded version, not on a placebo base.

The fourth is fragrance and color. The default Korean indie galactomyces essence is fragrance-free and clear to pale-yellow. Adding fragrance is technically possible but masks the ferment's natural mild yeasty note in a way that some K-beauty-literate consumers read as "this brand doesn't trust its ferment." Adding artificial color is uncommon and tends to read as a Western product attempting to mimic a K-beauty essence rather than the real thing.

The fifth is the claims line. The published literature supports structure-function claims about barrier support, hydration, antioxidant activity, and soothing. It does not support disease-treatment claims about atopic dermatitis, eczema, or psoriasis, even though the keratinocyte and 3D epidermis work touches on those mechanisms. Under MoCRA in the United States, a cosmetic that crosses into disease-treatment claims becomes a drug for regulatory purposes, with very different facility registration, GMP, and labeling obligations. Hold the claims at structure-function and you stay on the cosmetic side of the line.

Where Galactomyces Fits in a Routine

A 90-plus percent ferment essence sits at the first-essence step, immediately after toner and before serum, and is patted on with the hands rather than rubbed in with a cotton pad. The watery viscosity is intentional. The product is designed to deliver a high water-fraction load of the ferment metabolite mix to a freshly-cleansed and toned face, then absorb in 15 to 30 seconds without leaving a film. Layering a heavier serum and a moisturizer over the top is the standard K-beauty pattern.

A 50 to 75 percent ferment ampoule sits one step later, in the serum position, and is paired with a moisturizer over the top. The texture can be slightly thicker, especially if humectants like glycerin, panthenol, or betaine are loaded into the remaining formulation space at 2 to 5 percent each.

A 5 to 20 percent ferment serum sits at the serum step and behaves like whatever the dominant active is on top of the ferment. A "niacinamide 5% with galactomyces 10%" serum reads to the consumer as a niacinamide serum that also has galactomyces in it. The ferment provides barrier-support undertone without dictating the texture or the marketing position.

For an indie founder building a first three-SKU range, the most defensible structure is a galactomyces-dominant essence as the SKU that anchors the brand's K-beauty heritage credentials, paired with a more conventional second SKU (a moisturizer, a sunscreen, or a more familiar serum format) and a third SKU that demonstrates formulation depth. Leading with the essence makes the brand legible to the K-beauty-literate consumer who is the most likely first buyer, and gives the brand a defensible claims story rooted in published mechanism work.

What a Stability-Tested Ferment Essence Looks Like in Your Hand

A typical 90 to 95 percent galactomyces ferment essence in 2026 from a tier-one Korean ODM, after passing ICH Q1A(R2) accelerated stability at 40°C ± 2°C / 75% RH ± 5% RH for 90 days and ISO 11930 preservative efficacy testing, will arrive in your hand as a clear or very pale yellow liquid, with no perceptible fragrance, a watery viscosity in the 10 to 50 centipoise range, a pH in the 4.5 to 5.5 band, and a mild yeasty note on first opening that dissipates within seconds of application. Microbial count to ISO 17516:2014 limits (≤10³ CFU/g for general leave-on cosmetics) on day 90 of accelerated aging is the baseline gate.

If the sample arrives with visible particulate matter, a cloudy haze, a sharp solvent or alcohol note, a viscosity that is closer to honey than water, or a color noticeably darker than pale yellow, ask the lab for the certificate of analysis on that specific lot before approving. Any one of those signals is fixable upstream, but you want it fixed before production rather than after the first PO.

Reviewed for Accuracy

Reviewed for accuracy by ALTA MEET's formulation consulting team. Citations to the 2015 Takei et al. AhR paper, the 2022 anti-inflammaging study, the 2023 longitudinal hydration study, the 2024 cell-cell interaction study, and the 2024 amino acid profile work in Journal of Cosmetic Dermatological Sciences and Applications are drawn from peer-reviewed dermatology and cosmetic chemistry journals. Pricing and MOQ benchmarks reflect ALTA MEET's working consulting practice across indie K-beauty briefs in 2025 and 2026.

FAQ

Is galactomyces ferment filtrate the same as Pitera?

Pitera is SK-II's trademark name for its proprietary galactomyces ferment filtrate. The INCI is functionally the same ingredient (a Galactomyces / Geotrichum candidum ferment filtrate), but the upstream strain, fermentation conditions, filtration grade, and price point are all different from a commodity ferment supplied by a mid-tier Korean biotech house. A 90 percent galactomyces essence from a Korean indie brand is a legitimate adjacent product, not a counterfeit.

Can a US indie brand make a "supports skin barrier" claim with galactomyces?

In our reading of MoCRA structure-function claim territory, "supports the skin barrier" is a defensible cosmetic claim if you cite the published mechanism work on AhR-driven barrier protein expression. "Treats atopic dermatitis" or "cures eczema" is a disease claim that crosses into drug regulation. We recommend keeping all consumer-facing copy on the cosmetic side of that line and routing any clinical-style language through a qualified US safety assessor before publication.

What is the minimum ferment percentage that still makes the marketing claim work?

There is no regulatory floor. Marketing-wise, a product called "galactomyces essence" tends to be expected by K-beauty-literate consumers to be at least 75 percent ferment. A product called "galactomyces serum" or "galactomyces ampoule" can sit comfortably at 30 to 70 percent. A product that mentions galactomyces as one of several actives can drop to 5 to 20 percent without misleading the consumer. The percentage you choose should match the product noun on the label.

How long does an indie galactomyces essence project take from brief to first shippable carton?

Eight to 14 weeks from approved brief to first carton on the water for a stock-packaging, formula-from-benchmark project at 1,000 to 3,000 unit MOQ, and 10 to 16 weeks for a custom formula with adjuvant actives. Add 2 to 4 weeks for US MoCRA facility registration and product listing if you do not already have your facility registered.

Is fragrance acceptable in a galactomyces essence?

It is technically possible, but masking the ferment's natural mild yeasty note is generally read by K-beauty-literate consumers as a sign that the brand is uncomfortable with its own ingredient. We recommend fragrance-free as the default for a galactomyces-led first SKU.

Does galactomyces play well with niacinamide and panthenol?

Yes. Niacinamide at 2 to 5 percent and panthenol at 1 to 5 percent are common Korean ODM stack partners in the 50 to 75 percent ferment range. Both are stable at the typical 4.5 to 5.5 ferment pH, both contribute to barrier-support claims, and both extend the formula's appeal beyond consumers who are already galactomyces-literate.

What is the typical preservation system?

A combination of phenoxyethanol at approximately 0.5 to 0.9 percent, ethylhexylglycerin at 0.1 to 0.3 percent, and 1,2-hexanediol at 1 to 2 percent is the most commonly briefed Korean indie preservative stack on a high-ferment essence. Ask the ODM for the ISO 11930 preservative efficacy result on the finished ferment-loaded formula, not on the placebo base.

Working With ALTA MEET on Your First Galactomyces Brief

ALTA MEET is a New York-based cross-border sourcing partner for US indie K-beauty brands. We sit on the Manhattan side and brief Korean ODMs directly on your behalf, handle the upstream ingredient-supplier diligence, walk the cost stack with you in dollars rather than wons, and act as the product team you would otherwise have to hire in-house.

If you are about to write your first galactomyces brief and you want a working sense of whether your target percentage, your candidate ODM list, and your launch cost math actually fit together, book a free 15-min K-Beauty manufacturing gut-check with Liz. Two questions on the form, 15 minutes on the call, and you walk away with a real read on whether the brief you have drafted lines up with the product class you actually mean to launch.

*Sources cited inline: Takei et al., Clinical and Experimental Dermatology 2015 (AhR activation, filaggrin and loricrin upregulation); Journal of Clinical Medicine 202